Mannitol Injection, USP 25 %

Mannitol Injection, USP 25% is an intravenous solution used for various medical purposes, including fluid replacement and reducing intracranial pressure. This sterile solution is manufactured by Fresenius Kabi Canada Ltd.

Mannitol Injection, USP 25% is commonly used to promote diuresis, which helps the kidneys remove excess fluids and waste from the body. It is also used to reduce intracranial pressure and promote urine output in certain medical conditions. Mannitol is often administered intravenously to achieve these effects.

When administered, Mannitol Injection, USP 25% works by drawing water out of the tissues and into the bloodstream, which can help reduce swelling and pressure. This process can lead to increased urine production, helping to flush out excess fluids and waste products from the body.

Mannitol Injection, USP 25% should be used with caution in patients with certain medical conditions, such as heart failure or kidney disease. It is important to follow the advice of a healthcare provider when using this solution. Always check the label for any specific warnings or precautions.

Mannitol may interact with certain medications, including diuretics and corticosteroids. It is important to inform your healthcare provider about all medications you are taking before using Mannitol Injection, USP 25%. Additionally, alcohol and other substances may affect the way Mannitol works in the body.